Push Admin

Chinese military researchers move new COVID vaccine candidate into human trial

Article (news)

Roxanne Liu and Se Young Lee, Reuters

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2020/reuters/05/21/20200521-vaccine.jpg"/><figcaption>Small bottles labeled with a &quot;Vaccine COVID-19&quot; sticker and a medical syringe are seen in this illustration taken April 10, 2020. Dado Ruvic, Reuters/File</figcaption></figure></div>BEIJING - A Chinese military research institute has been approved to test its second experimental coronavirus vaccine in humans, the eighth candidate in clinical trials for China as it emerges as a front-runner in the global fight against COVID-19.No vaccine has been approved for sale against the virus that has killed over 470,000 people, but more than a dozen candidates have entered different stages of human test globally.The new drug is developed by the Academy of Military Science (AMS), a research institute affiliated with the People&#x27;s Liberation Army, and was approved to proceed to human trial by China&#x27;s National Medical Products Administration.AMS&#x27; latest candidate, named ARCoV, uses mRNA technology, an approach that is also used for candidates developed by Moderna Inc in the United States and German firm CureVac but has never been tested in China-based clinical trials, the institute said in its social media WeChat late on Wednesday.&quot;The core raw materials and equipment are all domestically produced, and rapid production capacity ramp-up is achievable,&quot; Qin Chengfeng, a researcher responsible for the mRNA project, said in the statement.The Chinese Clinical Trial registry, without naming ARCoV, said a phase 1 clinical trial for an mRNA vaccine, sponsored by AMS, Yunnan Walvax Biotechnology and Suzhou Abogen Biosciences, would start on Thursday and evaluate the safety of the candidate. http://www.chictr.org.cn/showproj.aspx?proj=55524Separately, Ad5-nCoV, a vaccine candidate co-developed by AMS and CanSino Biologics using a different technique, is under phase-2 clinical trial in China and has won approval to begin human testing in Canada.

A Chinese military research institute has been approved to test its second experimental coronavirus vaccine in humans, the eighth candidate in clinical trials for China as it emerges as a front-runner in the global fight against COVID-19.

A Chinese military research institute has been approved to test its second experimental coronavirus vaccine in humans, the eighth candidate in clinical trials for China as it emerges as a front-runner in the global fight against COVID-19.

Chinese military researchers move new COVID vaccine candidate into human trial

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

Overseas

Chinese military researchers move new COVID vaccine candidate into human trial

Roxanne Liu and Se Young Lee,

Reuters

Published Jun 25, 2020 02:27 AM PHT

Read More:

China

China military

Chinese military researchers

COVID-19

coronavirus

COVID-19 vaccine

coronavirus vaccine

China human trials

China vaccine trials

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.